Menu
01/05/2012
Breast Cancer Can Be Detected Years Before, According To Study
Dr James Flanagan, a Breast Cancer Campaign scientific fellow in the Department of Surgery and Cancer at Imperial College London, has uncovered the first strong evidence that molecular or 'epigenetic' changes in a gene can be associated with breast cancer risk and can be detected many years before breast cancer develops.
The research, which is published today in Cancer Research, involved 640 women with breast cancer and 741 controls who enrolled in three previous studies, the earliest of which began in 1992. The researchers analysed blood samples that the women donated on average three years before being diagnosed with breast cancer to find out whether the alteration of single genes by a process called methylation can predict whether women have an increased breast cancer risk.
Dr Flanagan found that the women with the highest level of methylation on one area of a gene called ATM were twice as likely to get breast cancer as women with the lowest level. This result was particularly clear in blood samples taken from women under the age of 60.
Importantly, because this is the first study using blood taken on average three years before diagnosis and in some cases up to eleven years, it shows that the genes were not altered because of active cancer in the body or by treatments for cancer, which has been a problem with previous studies that took blood after diagnosis.
Dr James Flanagan said: "These findings provide strong evidence that looking at this type of epigenetic alteration (methylation) on individual genes could be used as a blood test to help assess breast cancer risk. When used in combination with other risk assessment tools such as genetic testing and risk factor profiling, this simple blood test could identify those at higher risk, helping doctors to monitor and one day maybe even prevent breast cancer ever developing.
"The findings now need rigorous testing in many more individuals and many more genes that contribute to a person’s risk profile need to be identified, as this is just one gene that makes up a small component."
(CD/GK)
The research, which is published today in Cancer Research, involved 640 women with breast cancer and 741 controls who enrolled in three previous studies, the earliest of which began in 1992. The researchers analysed blood samples that the women donated on average three years before being diagnosed with breast cancer to find out whether the alteration of single genes by a process called methylation can predict whether women have an increased breast cancer risk.
Dr Flanagan found that the women with the highest level of methylation on one area of a gene called ATM were twice as likely to get breast cancer as women with the lowest level. This result was particularly clear in blood samples taken from women under the age of 60.
Importantly, because this is the first study using blood taken on average three years before diagnosis and in some cases up to eleven years, it shows that the genes were not altered because of active cancer in the body or by treatments for cancer, which has been a problem with previous studies that took blood after diagnosis.
Dr James Flanagan said: "These findings provide strong evidence that looking at this type of epigenetic alteration (methylation) on individual genes could be used as a blood test to help assess breast cancer risk. When used in combination with other risk assessment tools such as genetic testing and risk factor profiling, this simple blood test could identify those at higher risk, helping doctors to monitor and one day maybe even prevent breast cancer ever developing.
"The findings now need rigorous testing in many more individuals and many more genes that contribute to a person’s risk profile need to be identified, as this is just one gene that makes up a small component."
(CD/GK)
Related UK National News Stories
Click here for the latest headlines.
27 June 2014
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
12 April 2006
Breast cancer patient wins Herceptin court battle
A breast cancer patient has won an appeal to receive the drug Herceptin on the NHS. Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
Breast cancer patient wins Herceptin court battle
A breast cancer patient has won an appeal to receive the drug Herceptin on the NHS. Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
17 October 2005
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
10 October 2005
Breast cancer survival rates rise
Almost two-thirds of all women newly diagnosed with breast cancer are now likely to survive for at least 20 years, a leading cancer charity has claimed.
Breast cancer survival rates rise
Almost two-thirds of all women newly diagnosed with breast cancer are now likely to survive for at least 20 years, a leading cancer charity has claimed.
08 August 2003
HRT therapy can double breast cancer risk
Certain kinds of hormone replacement therapy (HRT) can double a woman's risk of breast cancer, according to major research study of more than a million women. Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer as non-users.
HRT therapy can double breast cancer risk
Certain kinds of hormone replacement therapy (HRT) can double a woman's risk of breast cancer, according to major research study of more than a million women. Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer as non-users.
-
Northern Ireland WeatherThis Evening and Tonight:A cloudy evening and night with a little light rain or drizzle, perhaps some clear periods developing along the east coast. A very mild night everywhere. Minimum temperature 7 °C.
